Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 275 No 7361 p173
6 August 2005


Society summary


National boards given go-ahead

The Council of the Royal Pharmaceutical Society agreed on 2 August to establish three national pharmacy boards for England, Scotland and Wales to provide strategic leadership and support for pharmacy practice development at a national level.

The decision followed discussion of the results of the Council consultation on the recommendations of the Devolution Review Group, chaired by Lord Fraser of Carmyllie.

The new national pharmacy boards will develop and implement country-specific policy related to the practice of pharmacy and will support pharmacists in practice and assist development of overarching Council policy for Britain. The three bodies will take the lead in promoting pharmacy and its contribution to health to government and its agencies, NHS bodies, and other health and social care organisations and support the membership through the Society’s branches.

In Scotland and Wales the existing executives are to be replaced by boards complete with new devolved powers. In England a new board will be created to operate from the Society’s London headquarters.

The Council also agreed that the precise nature of its working arrangements with the boards will be set out in a series of concordats, to be developed by the end of this year.

Commenting on this historic decision, the Society’s President, Hemant Patel, said: “The Council was united in agreement that the Society must respond positively to the devolution agenda of government. We must ensure that pharmacists in Scotland, Wales and England are supported in their work in what are increasingly three distinctly individually flavoured national health services. Lord Fraser’s review showed us the way and pharmacists and pharmacy organisations have, in a significant majority, responded positively to the proposals. The Council is now setting in train processes that will lead us to three national boards holding their first meetings in 2006.”

The chairman of the Scottish Executive, Angela Timoney, said: “I am delighted that the Council has listened to the views of members and acted upon them. I believe the creation of three national boards will strengthen the Society as a GB organisation and enable pharmacists to work more effectively with governments in each of the countries to the benefit of public, patients and the profession.”

Peter Jones, chairman of the Welsh Executive, said: “The agreement of Council to the establishment of three national boards will provide the Society with a robust framework to maximise the opportunities that devolution offers the profession of pharmacy. The Welsh Executive will continue to support the work that will now need to be undertaken in the establishment of these structures, their ways of working and their interaction with Council and its committees.”

Jonathan Buisson, member of Council for England, said: “I am pleased that the Council has had the courage to take this far-reaching decision. The English national board will be the success that members make of it and I hope that they will engage with the next debate, which is about its constitution.”

Back to Top


©The Pharmaceutical Journal